Search

everythinglearnresearchcommunity

for

Search:↓

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

The method effectively measures drug impact on DHT levels in prostate treatments.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

MK-5108 is safe and shows potential against tumors, especially alone.

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.

PCAT1 and HOTAIR levels are lower in people with androgenic alopecia.

Baricitinib was effective in treating both early and late onset alopecia areata.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Current methods can't accurately predict which long-form answers people prefer; evaluations should consider different answer qualities separately.

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

Alopecia areata incognita causes sudden hair loss but usually improves with topical steroids.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Topical minoxidil improves life quality for women with hair loss.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.